Total Payments
$3,021
2024 Payments
$814.84
Companies
15
Transactions
95
Medicare Patients
991
Medicare Billing
$175,927
Payment Breakdown by Category
Food & Beverage$2,991 (99.0%)
Education$29.99 (1.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,991 | 94 | 99.0% |
| Education | $29.99 | 1 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $641.02 | 22 | $0 (2020) |
| ABBVIE INC. | $492.17 | 14 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $298.64 | 7 | $0 (2022) |
| Neurocrine Biosciences, Inc. | $274.62 | 5 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $248.51 | 7 | $0 (2023) |
| Alkermes, Inc. | $241.81 | 6 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $192.57 | 5 | $0 (2024) |
| Lundbeck LLC | $164.64 | 8 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $139.19 | 6 | $0 (2024) |
| Corium, LLC | $109.45 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $814.84 | 23 | ABBVIE INC. ($311.09) |
| 2023 | $660.45 | 26 | AbbVie Inc. ($181.08) |
| 2022 | $238.59 | 7 | Otsuka America Pharmaceutical, Inc. ($185.58) |
| 2021 | $179.85 | 7 | Neurocrine Biosciences, Inc. ($99.62) |
| 2020 | $13.85 | 1 | Allergan, Inc. ($13.85) |
| 2019 | $495.61 | 16 | Allergan Inc. ($368.66) |
| 2018 | $443.11 | 12 | Alkermes, Inc. ($138.13) |
| 2017 | $175.04 | 3 | Allergan Inc. ($138.33) |
All Payment Transactions
95 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/27/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: PSYCHIATRY | ||||||
| 11/06/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $27.00 | General |
| Category: PSYCHIATRY | ||||||
| 10/15/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $30.63 | General |
| Category: PSYCHIATRY | ||||||
| 10/08/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $25.16 | General |
| Category: PSYCHIATRY | ||||||
| 09/24/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $135.36 | General |
| Category: Neuropsychiatry | ||||||
| 08/14/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $28.80 | General |
| Category: PSYCHIATRY | ||||||
| 08/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.11 | General |
| Category: NEUROSCIENCE | ||||||
| 07/23/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: PSYCHIATRY | ||||||
| 07/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.54 | General |
| Category: NEUROSCIENCE | ||||||
| 06/06/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $42.45 | General |
| Category: Neuroscience | ||||||
| 05/21/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: Neurology | ||||||
| 05/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.34 | General |
| Category: NEUROSCIENCE | ||||||
| 05/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.86 | General |
| Category: NEUROSCIENCE | ||||||
| 04/29/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: Central Nervous System | ||||||
| 04/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.26 | General |
| Category: NEUROSCIENCE | ||||||
| 04/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $145.18 | General |
| Category: NEUROSCIENCE | ||||||
| 03/27/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: Neurology | ||||||
| 03/27/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: PSYCHIATRY | ||||||
| 03/20/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: PSYCHIATRY | ||||||
| 03/11/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: Central Nervous System | ||||||
| 02/27/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: CNS | ||||||
| 01/30/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $43.11 | General |
| Category: Neuroscience | ||||||
| 01/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $124.80 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2023 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $28.36 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 12/07/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $5.77 | General |
| Category: CNS Stimulant for ADHD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 37 | 201 | $26,856 | $15,764 |
| 2022 | 2 | 24 | 37 | $3,467 | $2,572 |
| 2021 | 4 | 457 | 1,087 | $123,819 | $89,481 |
| 2020 | 8 | 473 | 960 | $100,814 | $68,110 |
Total Patients
991
Total Services
2,285
Medicare Billing
$175,927
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 37 | 201 | $26,856 | $15,764 | 58.7% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 12 | 23 | $1,977 | $1,426 | 72.1% |
| 90838 | Psychotherapy with evaluation and management visit, 1 hour | Office | 2022 | 12 | 14 | $1,490 | $1,146 | 76.9% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Office | 2021 | 138 | 468 | $53,076 | $38,416 | 72.4% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 134 | 431 | $37,588 | $27,026 | 71.9% |
| 99306 | Initial nursing facility visit, typically 45 minutes per day | Office | 2021 | 94 | 96 | $19,815 | $14,338 | 72.4% |
| 90838 | Psychotherapy with evaluation and management visit, 60 minutes | Office | 2021 | 91 | 92 | $13,340 | $9,702 | 72.7% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 178 | 390 | $32,090 | $23,718 | 73.9% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Office | 2020 | 137 | 284 | $32,208 | $23,586 | 73.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 44 | 103 | $13,762 | $6,389 | 46.4% |
| 90836 | Psychotherapy, 45 minutes | Office | 2020 | 31 | 51 | $4,648 | $3,696 | 79.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 15 | 33 | $5,926 | $3,226 | 54.4% |
| 99306 | Initial nursing facility visit, typically 45 minutes per day | Office | 2020 | 18 | 18 | $3,715 | $2,721 | 73.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 27 | 58 | $5,278 | $2,491 | 47.2% |
| 90838 | Psychotherapy, 60 minutes | Office | 2020 | 23 | 23 | $3,187 | $2,283 | 71.6% |
About Thomas Shaver
Thomas Shaver is a Psychiatry healthcare provider based in Washington, District of Columbia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/29/2013. The National Provider Identifier (NPI) number assigned to this provider is 1790120137.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Thomas Shaver has received a total of $3,021 in payments from pharmaceutical and medical device companies, with $814.84 received in 2024. These payments were reported across 95 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($2,991).
As a Medicare-enrolled provider, Shaver has provided services to 991 Medicare beneficiaries, totaling 2,285 services with total Medicare billing of $175,927. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Washington, DC
- Active Since 04/29/2013
- Last Updated 06/27/2018
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1790120137
Products in Payments
- VRAYLAR (Drug) $1,133
- LATUDA (Drug) $298.64
- INGREZZA (Drug) $274.62
- ABILIFY MAINTENA (Drug) $208.30
- INVEGA SUSTENNA (Drug) $163.12
- Aristada 441 mg (Drug) $160.47
- CAPLYTA (Drug) $159.17
- REXULTI (Drug) $120.77
- Azstarys (Drug) $109.45
- ABILIFY ASIMTUFII (Drug) $84.08
- ARISTADA (Drug) $81.34
- Austedo XR (Drug) $62.64
- UZEDY (Drug) $45.17
- INVEGA (Drug) $29.45
- HETLIOZ (Drug) $28.36
- Fanapt (Drug) $18.67
- FANAPT (Drug) $17.75
- ISENTRESS (Drug) $14.37
- NUEDEXTA (Drug) $11.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Washington
Tony Gore, Md, MD
Psychiatry — Payments: $67,343
Psychiatry $67,343
Thomas Mellman, Md, MD
Psychiatry — Payments: $35,366
Psychiatry $35,366
Mrs. Mona Mikhail, Md, MD
Psychiatry — Payments: $13,397
Psychiatry $13,397
Igor Volkov, M.d, M.D
Psychiatry — Payments: $9,586
Psychiatry $9,586
Yavar Moghimi, M.d, M.D
Psychiatry — Payments: $6,368
Psychiatry $6,368
Mr. Bernard Vittone, M.d, M.D
Psychiatry — Payments: $5,822
Psychiatry $5,822